PMDA drug package insert
サワシリンカプセル125
PMDA Prescription drug · LTLファーマ株式会社 · package insert Aug 29, 2025
Key facts
| Brand names | サワシリンカプセル125, サワシリンカプセル250, サワシリン細粒10%, サワシリン錠250 |
|---|---|
| Nonproprietary names | アモキシシリン水和物 |
| Companies | 製造販売／LTLファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 合成ペニシリン製剤 |
| Therapeutic category codes | 876131 |
| YJ codes | 6131001M1088, 6131001M2300, 6131001C1210, 6131001F2026 |
| Approval numbers | 22200AMX00974, 22000AMX01586, 22000AMX01585, 15400EMZ00930 |
| Package insert edition | 第5版 |
| Package insert date | Aug 29, 2025 |
| PMDA document key | 171911_6131001C1210_2 |
| PMDA company code | 171911 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: